2010 | 2009 | 2008 | 2007 | 2006 | 2005
Keyword Search
 
Date Title
07/28/10Printer Friendly VersionAllos Therapeutics Reports Second Quarter 2010 Financial Results
07/28/10Printer Friendly VersionAllos Therapeutics Announces Topline Results from Phase 2b Study of FOLOTYN in Patients with Advanced Non-Small Cell Lung Cancer
07/12/10Printer Friendly VersionAllos Therapeutics to Report Second Quarter 2010 Financial Results on July 28, 2010
06/17/10Printer Friendly VersionAllos Therapeutics' Pralatrexate Granted Orphan Medicinal Product Designation for the Treatment of Cutaneous T-Cell Lymphoma by the European Commission
06/11/10Printer Friendly VersionAllos Therapeutics' FOLOTYN Shows Activity and Tolerability in Phase 1 Dose Finding Study in Patients with Relapsed or Refractory CTCL
06/05/10Printer Friendly VersionAllos Therapeutics Reports New Data Demonstrating that Responses to FOLOTYN are Correlated with Prolonged Survival in Patients with Relapsed or Refractory PTCL
06/04/10Printer Friendly VersionAllos Therapeutics to Present at Four Upcoming Investor Conferences
06/01/10Printer Friendly VersionAllos Therapeutics Announces FOLOTYN(R) Data Presentations at the American Society of Clinical Oncology and the Congress of the European Hematology Association
05/20/10Printer Friendly VersionAllos Therapeutics to Present at the Citi Investment Research Global Health Care Conference
05/18/10Printer Friendly VersionAllos Therapeutics' Pralatrexate Granted FDA Orphan Drug Designation for the Treatment of Bladder Cancer
05/05/10Printer Friendly VersionAllos Therapeutics Reports First Quarter 2010 Financial Results
04/27/10Printer Friendly VersionAllos Therapeutics Appoints Dr. Charles Morris as Chief Medical Officer
04/21/10Printer Friendly VersionAllos Therapeutics to Report First Quarter 2010 Financial Results on May 5, 2010
03/01/10Printer Friendly VersionAllos Therapeutics Reports Fourth Quarter and Full Year 2009 Financial Results
02/24/10Printer Friendly VersionAllos Therapeutics to Participate in RBC Capital Markets Health Care Conference
02/17/10Printer Friendly VersionAllos Therapeutics to Report Fourth Quarter and Full Year 2009 Results on March 1, 2010
02/03/10Printer Friendly VersionAllos Therapeutics to Present at BIO CEO & Investor Conference
01/06/10Printer Friendly VersionAllos Therapeutics to Present at J.P. Morgan Healthcare Conference
Receive E-mail Alerts
Sign up to receive e-mail alerts whenever Allos Therapeutics, Inc. has a news release. Just enter your e-mail address and click Submit.